Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SSR150106XB versus placebo for post-dental surgery pain after third molar extraction
2005-005478-66Phase 2Completed
- Sponsor
- Sanofi
- Start
- Feb 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in acute postoperative pain comparing SSR150106XB with Placebo (2 arms). Primary endpoint: Summed pain intensity differences from baseline to 8 hours. Started Feb 2006; status: completed.
02
Drugs
SSR150106
03
Conditions
acute postoperative pain
Beyond the preview
Go deeper on 2005-005478-66.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005478-66.